The Texas Legislature is considering three risky bills that would give free rein to stem cell clinics to profit big time off of patients by selling unproven and unapproved “stem cell treatments” that have little if any science behind them. I call one of these bills “Right to Profit” for clinics, which if these became […]
Risky Pro-Stem Cell Clinic Bills Still Alive in Texas Legislature Read More »
Every few years I do a survey of you guys so I can have a better sense of my blog’s readership. For that purpose, below I’ve got two polls to ask you (1) about your general backgrounds and (2) preferences about post content. Because some people may want to vote more than once on the
Stem Cell Blog Reader Survey, Free Swag Read More »
The Calexit and Texit state secession campaigns for California and Texas to leave the union, which are linked to Russian President Putin, are never going to be successful. However, if some Texas lawmakers and stem cell clinics there have their way, Texas would take a big step away from the rest of us on the stem cell
3 Dangerous Texas Bills Would Boost Stem Cell Clinics Read More »
What’s the hardest thing we ever do with our brains on average during a lifetime? Our brains are wonderful things that some have called the most complicated structures in the known universe, but what exactly do we do with them? Do we tax them fully during our lives? The old cliché that we only use
What is hardest thing we do with our brains in a lifetime? Read More »
The 21st Century Cures Act has some important regenerative medicine language in it. One part of that was attempting to accelerate FDA review of promising investigation regenerative medicine therapies. The mechanism for this was a new designation called Regenerative Advanced Therapy, now renamed Regenerative Medicine Advanced Therapy (RMAT) Designation. I don’t think anyone was sure
Big change for stem cell field with FDA quickly issuing RMATs Read More »
Today’s post is the last of a three-part series on the Burt stem cell trials at Northwestern. This piece is focused on funding and the future of the trial, and also includes perspectives from patients. You can read Part 1 here and Part 2 here, which focused on issues related to potential encouragement of patient fundraising that unintentionally releases
Burt Northwestern Stem Cell MS Trial Part 3: Funding, Patient Perspectives, & the Future Read More »
CIRM announced today that its President and CEO, Randy Mills, is soon leaving for a new job as President of the National Marrow Donor Program/Be The Match in Minnesota. Update: Dr. Maria Millan, the CIRM Vice President of Therapeutics, will be its leader starting July 1 until a new leader is chosen. For this kind of
President Mills Leaving, CIRM Needs New Leader to Navigate Future Challenges Read More »
By Jeanne Loring “Mutation” and “cancer” are eye-catching words for a headline; add “stem cells” and there is a good chance that a lot of people will hear about it. These words have been liberally used in the press to describe the results of a recent publication: “Human pluripotent stem cells recurrently acquire and expand
Mutations in pluripotent stem cells: No, the sky is not falling Read More »
Over at the California Stem Cell Report, David Jensen is reporting on some good news from CIRM for California on the stem cell clinical trial front. Stem cell biotechs Asterias and Capricor have stem cell trials supported by 20+ million in CIRM funding each and have been hitting milestones. These trials are progressing and so far have good safety
Upbeat prospects for some California clinical trial efforts from CIRM Read More »
In case you have some free time for reading this week, here’s a list containing an assortment of interesting research articles and stem cell headlines. I’ve thrown some oddballs in there too including one article from May 1983, when I was just finishing up junior high. No, I didn’t write it. And no the headline
A TGIF weekend reading list of new stem cell pubs & headlines Read More »